Muscle Spasm Therapy Market, Global Outlook and Forecast 2022-2028

February 2022 | 68 pages | ID: MA5EE6D58DC0EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Muscle Spasm Therapy in Global, including the following market information:

Global Muscle Spasm Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Muscle Spasm Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Muscular Injury Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Muscle Spasm Therapy include Amgen, Inc., Eisai Co., Ltd., Novartis International AG, GlaxoSmithKline plc, AstraZeneca plc, Pfizer, Inc. and F. Hoffmann La Roche Ltd., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Muscle Spasm Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Muscle Spasm Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Muscle Spasm Therapy Market Segment Percentages, by Type, 2021 (%)

• Muscular Injury
• Spinal Nerve Compression
• Sprains and Strains of the Muscle Diabetic Ketoacidosis
• Others

Global Muscle Spasm Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Muscle Spasm Therapy Market Segment Percentages, by Application, 2021 (%)

• Construction
• Fire-Fighting
• Sports Apparel
• Automotive
• Aerospace
• Military & Defence
• Industrial
• Others

Global Muscle Spasm Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Muscle Spasm Therapy Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Muscle Spasm Therapy revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Muscle Spasm Therapy revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Amgen, Inc.
• Eisai Co., Ltd.
• Novartis International AG
• GlaxoSmithKline plc
• AstraZeneca plc
• Pfizer, Inc.
• F. Hoffmann La Roche Ltd.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Muscle Spasm Therapy Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Muscle Spasm Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL MUSCLE SPASM THERAPY OVERALL MARKET SIZE

2.1 Global Muscle Spasm Therapy Market Size: 2021 VS 2028
2.2 Global Muscle Spasm Therapy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Muscle Spasm Therapy Players in Global Market
3.2 Top Global Muscle Spasm Therapy Companies Ranked by Revenue
3.3 Global Muscle Spasm Therapy Revenue by Companies
3.4 Top 3 and Top 5 Muscle Spasm Therapy Companies in Global Market, by Revenue in 2021
3.5 Global Companies Muscle Spasm Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Muscle Spasm Therapy Players in Global Market
  3.6.1 List of Global Tier 1 Muscle Spasm Therapy Companies
  3.6.2 List of Global Tier 2 and Tier 3 Muscle Spasm Therapy Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Muscle Spasm Therapy Market Size Markets, 2021 & 2028
  4.1.2 Muscular Injury
  4.1.3 Spinal Nerve Compression
  4.1.4 Sprains and Strains of the Muscle Diabetic Ketoacidosis
  4.1.5 Others
4.2 By Type - Global Muscle Spasm Therapy Revenue & Forecasts
  4.2.1 By Type - Global Muscle Spasm Therapy Revenue, 2017-2022
  4.2.2 By Type - Global Muscle Spasm Therapy Revenue, 2023-2028
  4.2.3 By Type - Global Muscle Spasm Therapy Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Muscle Spasm Therapy Market Size, 2021 & 2028
  5.1.2 Construction
  5.1.3 Fire-Fighting
  5.1.4 Sports Apparel
  5.1.5 Automotive
  5.1.6 Aerospace
  5.1.7 Military & Defence
  5.1.8 Industrial
  5.1.9 Others
5.2 By Application - Global Muscle Spasm Therapy Revenue & Forecasts
  5.2.1 By Application - Global Muscle Spasm Therapy Revenue, 2017-2022
  5.2.2 By Application - Global Muscle Spasm Therapy Revenue, 2023-2028
  5.2.3 By Application - Global Muscle Spasm Therapy Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Muscle Spasm Therapy Market Size, 2021 & 2028
6.2 By Region - Global Muscle Spasm Therapy Revenue & Forecasts
  6.2.1 By Region - Global Muscle Spasm Therapy Revenue, 2017-2022
  6.2.2 By Region - Global Muscle Spasm Therapy Revenue, 2023-2028
  6.2.3 By Region - Global Muscle Spasm Therapy Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Muscle Spasm Therapy Revenue, 2017-2028
  6.3.2 US Muscle Spasm Therapy Market Size, 2017-2028
  6.3.3 Canada Muscle Spasm Therapy Market Size, 2017-2028
  6.3.4 Mexico Muscle Spasm Therapy Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Muscle Spasm Therapy Revenue, 2017-2028
  6.4.2 Germany Muscle Spasm Therapy Market Size, 2017-2028
  6.4.3 France Muscle Spasm Therapy Market Size, 2017-2028
  6.4.4 U.K. Muscle Spasm Therapy Market Size, 2017-2028
  6.4.5 Italy Muscle Spasm Therapy Market Size, 2017-2028
  6.4.6 Russia Muscle Spasm Therapy Market Size, 2017-2028
  6.4.7 Nordic Countries Muscle Spasm Therapy Market Size, 2017-2028
  6.4.8 Benelux Muscle Spasm Therapy Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Muscle Spasm Therapy Revenue, 2017-2028
  6.5.2 China Muscle Spasm Therapy Market Size, 2017-2028
  6.5.3 Japan Muscle Spasm Therapy Market Size, 2017-2028
  6.5.4 South Korea Muscle Spasm Therapy Market Size, 2017-2028
  6.5.5 Southeast Asia Muscle Spasm Therapy Market Size, 2017-2028
  6.5.6 India Muscle Spasm Therapy Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Muscle Spasm Therapy Revenue, 2017-2028
  6.6.2 Brazil Muscle Spasm Therapy Market Size, 2017-2028
  6.6.3 Argentina Muscle Spasm Therapy Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Muscle Spasm Therapy Revenue, 2017-2028
  6.7.2 Turkey Muscle Spasm Therapy Market Size, 2017-2028
  6.7.3 Israel Muscle Spasm Therapy Market Size, 2017-2028
  6.7.4 Saudi Arabia Muscle Spasm Therapy Market Size, 2017-2028
  6.7.5 UAE Muscle Spasm Therapy Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Amgen, Inc.
  7.1.1 Amgen, Inc. Corporate Summary
  7.1.2 Amgen, Inc. Business Overview
  7.1.3 Amgen, Inc. Muscle Spasm Therapy Major Product Offerings
  7.1.4 Amgen, Inc. Muscle Spasm Therapy Revenue in Global Market (2017-2022)
  7.1.5 Amgen, Inc. Key News
7.2 Eisai Co., Ltd.
  7.2.1 Eisai Co., Ltd. Corporate Summary
  7.2.2 Eisai Co., Ltd. Business Overview
  7.2.3 Eisai Co., Ltd. Muscle Spasm Therapy Major Product Offerings
  7.2.4 Eisai Co., Ltd. Muscle Spasm Therapy Revenue in Global Market (2017-2022)
  7.2.5 Eisai Co., Ltd. Key News
7.3 Novartis International AG
  7.3.1 Novartis International AG Corporate Summary
  7.3.2 Novartis International AG Business Overview
  7.3.3 Novartis International AG Muscle Spasm Therapy Major Product Offerings
  7.3.4 Novartis International AG Muscle Spasm Therapy Revenue in Global Market (2017-2022)
  7.3.5 Novartis International AG Key News
7.4 GlaxoSmithKline plc
  7.4.1 GlaxoSmithKline plc Corporate Summary
  7.4.2 GlaxoSmithKline plc Business Overview
  7.4.3 GlaxoSmithKline plc Muscle Spasm Therapy Major Product Offerings
  7.4.4 GlaxoSmithKline plc Muscle Spasm Therapy Revenue in Global Market (2017-2022)
  7.4.5 GlaxoSmithKline plc Key News
7.5 AstraZeneca plc
  7.5.1 AstraZeneca plc Corporate Summary
  7.5.2 AstraZeneca plc Business Overview
  7.5.3 AstraZeneca plc Muscle Spasm Therapy Major Product Offerings
  7.5.4 AstraZeneca plc Muscle Spasm Therapy Revenue in Global Market (2017-2022)
  7.5.5 AstraZeneca plc Key News
7.6 Pfizer, Inc.
  7.6.1 Pfizer, Inc. Corporate Summary
  7.6.2 Pfizer, Inc. Business Overview
  7.6.3 Pfizer, Inc. Muscle Spasm Therapy Major Product Offerings
  7.6.4 Pfizer, Inc. Muscle Spasm Therapy Revenue in Global Market (2017-2022)
  7.6.5 Pfizer, Inc. Key News
7.7 F. Hoffmann La Roche Ltd.
  7.7.1 F. Hoffmann La Roche Ltd. Corporate Summary
  7.7.2 F. Hoffmann La Roche Ltd. Business Overview
  7.7.3 F. Hoffmann La Roche Ltd. Muscle Spasm Therapy Major Product Offerings
  7.7.4 F. Hoffmann La Roche Ltd. Muscle Spasm Therapy Revenue in Global Market (2017-2022)
  7.7.5 F. Hoffmann La Roche Ltd. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Muscle Spasm Therapy Market Opportunities & Trends in Global Market
Table 2. Muscle Spasm Therapy Market Drivers in Global Market
Table 3. Muscle Spasm Therapy Market Restraints in Global Market
Table 4. Key Players of Muscle Spasm Therapy in Global Market
Table 5. Top Muscle Spasm Therapy Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Muscle Spasm Therapy Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Muscle Spasm Therapy Revenue Share by Companies, 2017-2022
Table 8. Global Companies Muscle Spasm Therapy Product Type
Table 9. List of Global Tier 1 Muscle Spasm Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Muscle Spasm Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Muscle Spasm Therapy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Muscle Spasm Therapy Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Muscle Spasm Therapy Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Muscle Spasm Therapy Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Muscle Spasm Therapy Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Muscle Spasm Therapy Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Muscle Spasm Therapy Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Muscle Spasm Therapy Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Muscle Spasm Therapy Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Muscle Spasm Therapy Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Muscle Spasm Therapy Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Muscle Spasm Therapy Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Muscle Spasm Therapy Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Muscle Spasm Therapy Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Muscle Spasm Therapy Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Muscle Spasm Therapy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Muscle Spasm Therapy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Muscle Spasm Therapy Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Muscle Spasm Therapy Revenue, (US$, Mn), 2023-2028
Table 30. Amgen, Inc. Corporate Summary
Table 31. Amgen, Inc. Muscle Spasm Therapy Product Offerings
Table 32. Amgen, Inc. Muscle Spasm Therapy Revenue (US$, Mn), (2017-2022)
Table 33. Eisai Co., Ltd. Corporate Summary
Table 34. Eisai Co., Ltd. Muscle Spasm Therapy Product Offerings
Table 35. Eisai Co., Ltd. Muscle Spasm Therapy Revenue (US$, Mn), (2017-2022)
Table 36. Novartis International AG Corporate Summary
Table 37. Novartis International AG Muscle Spasm Therapy Product Offerings
Table 38. Novartis International AG Muscle Spasm Therapy Revenue (US$, Mn), (2017-2022)
Table 39. GlaxoSmithKline plc Corporate Summary
Table 40. GlaxoSmithKline plc Muscle Spasm Therapy Product Offerings
Table 41. GlaxoSmithKline plc Muscle Spasm Therapy Revenue (US$, Mn), (2017-2022)
Table 42. AstraZeneca plc Corporate Summary
Table 43. AstraZeneca plc Muscle Spasm Therapy Product Offerings
Table 44. AstraZeneca plc Muscle Spasm Therapy Revenue (US$, Mn), (2017-2022)
Table 45. Pfizer, Inc. Corporate Summary
Table 46. Pfizer, Inc. Muscle Spasm Therapy Product Offerings
Table 47. Pfizer, Inc. Muscle Spasm Therapy Revenue (US$, Mn), (2017-2022)
Table 48. F. Hoffmann La Roche Ltd. Corporate Summary
Table 49. F. Hoffmann La Roche Ltd. Muscle Spasm Therapy Product Offerings
Table 50. F. Hoffmann La Roche Ltd. Muscle Spasm Therapy Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Muscle Spasm Therapy Segment by Type in 2021
Figure 2. Muscle Spasm Therapy Segment by Application in 2021
Figure 3. Global Muscle Spasm Therapy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Muscle Spasm Therapy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Muscle Spasm Therapy Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Muscle Spasm Therapy Revenue in 2021
Figure 8. By Type - Global Muscle Spasm Therapy Revenue Market Share, 2017-2028
Figure 9. By Application - Global Muscle Spasm Therapy Revenue Market Share, 2017-2028
Figure 10. By Region - Global Muscle Spasm Therapy Revenue Market Share, 2017-2028
Figure 11. By Country - North America Muscle Spasm Therapy Revenue Market Share, 2017-2028
Figure 12. US Muscle Spasm Therapy Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Muscle Spasm Therapy Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Muscle Spasm Therapy Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Muscle Spasm Therapy Revenue Market Share, 2017-2028
Figure 16. Germany Muscle Spasm Therapy Revenue, (US$, Mn), 2017-2028
Figure 17. France Muscle Spasm Therapy Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Muscle Spasm Therapy Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Muscle Spasm Therapy Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Muscle Spasm Therapy Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Muscle Spasm Therapy Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Muscle Spasm Therapy Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Muscle Spasm Therapy Revenue Market Share, 2017-2028
Figure 24. China Muscle Spasm Therapy Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Muscle Spasm Therapy Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Muscle Spasm Therapy Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Muscle Spasm Therapy Revenue, (US$, Mn), 2017-2028
Figure 28. India Muscle Spasm Therapy Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Muscle Spasm Therapy Revenue Market Share, 2017-2028
Figure 30. Brazil Muscle Spasm Therapy Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Muscle Spasm Therapy Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Muscle Spasm Therapy Revenue Market Share, 2017-2028
Figure 33. Turkey Muscle Spasm Therapy Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Muscle Spasm Therapy Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Muscle Spasm Therapy Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Muscle Spasm Therapy Revenue, (US$, Mn), 2017-2028
Figure 37. Amgen, Inc. Muscle Spasm Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Eisai Co., Ltd. Muscle Spasm Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novartis International AG Muscle Spasm Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. GlaxoSmithKline plc Muscle Spasm Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. AstraZeneca plc Muscle Spasm Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Pfizer, Inc. Muscle Spasm Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. F. Hoffmann La Roche Ltd. Muscle Spasm Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)